Cipla Arthritis Drug Found By India Inspectors To Be Substandard
This article was originally published in PharmAsia News
Executive Summary
Cipla faces possible sanctions from the Drug Controller General of India, which found a sampling of one of its drugs considered to be of substandard quality, an official said.